{
    "paper_id": "96f64ae561bd2bdf19f6ab4904f36c3b34b623ba",
    "metadata": {
        "title": "European Association of Urology Guidelines Office Rapid Reaction European Association of Urology Guidelines Recommendations to on behalf of the GORRG",
        "authors": [
            {
                "first": "Maria",
                "middle": [
                    "J"
                ],
                "last": "Ribal Q2 Q3",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Philip",
                "middle": [],
                "last": "Cornford",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Liverpool University Hospitals Foundation NHS Trust",
                    "location": {
                        "settlement": "Liverpool",
                        "country": "UK"
                    }
                },
                "email": ""
            },
            {
                "first": "Alberto",
                "middle": [],
                "last": "Briganti",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "IRCCS Ospedale San Raffaele",
                    "location": {
                        "settlement": "Milan",
                        "country": "Italy"
                    }
                },
                "email": ""
            },
            {
                "first": "Thomas",
                "middle": [],
                "last": "Knoll",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of T\u00fcbingen",
                    "location": {
                        "settlement": "Sindelfingen-20, Sindelfingen",
                        "country": "Germany"
                    }
                },
                "email": ""
            },
            {
                "first": "Stavros",
                "middle": [],
                "last": "Gravas",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University Hospital of Larissa",
                    "location": {
                        "settlement": "Larissa",
                        "country": "Greece; 21"
                    }
                },
                "email": ""
            },
            {
                "first": "Marek",
                "middle": [],
                "last": "Babjuk",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Charles University",
                    "location": {
                        "settlement": "Prague",
                        "country": "Czech Republic"
                    }
                },
                "email": ""
            },
            {
                "first": "Christopher",
                "middle": [],
                "last": "Harding",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Freeman Hospital",
                    "location": {
                        "settlement": "Newcastle-upon-Tyne",
                        "country": "UK"
                    }
                },
                "email": ""
            },
            {
                "first": "Alberto",
                "middle": [],
                "last": "Breda",
                "suffix": "",
                "affiliation": {
                    "laboratory": "Oncology Urology Unit",
                    "institution": "Universitat Aut\u00f2noma de Barcelona",
                    "location": {
                        "addrLine": "Fundaci\u00f3 23 Puigvert",
                        "settlement": "Barcelona",
                        "country": "Spain"
                    }
                },
                "email": ""
            },
            {
                "first": "Axel",
                "middle": [],
                "last": "Bex",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Antoni van Leeuwenhoek Hospital",
                    "location": {
                        "addrLine": "The Netherlands Cancer Institute, Amsterdam, 25",
                        "country": "The Netherlands"
                    }
                },
                "email": ""
            },
            {
                "first": "Jens",
                "middle": [
                    "J"
                ],
                "last": "Group",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "",
                "middle": [],
                "last": "Rassweiler",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Heidelberg",
                    "location": {
                        "settlement": "Heilbronn",
                        "country": "Germany"
                    }
                },
                "email": ""
            },
            {
                "first": "Ali",
                "middle": [
                    "S"
                ],
                "last": "G\u00f6zen",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Heidelberg",
                    "location": {
                        "settlement": "Heilbronn",
                        "country": "Germany"
                    }
                },
                "email": ""
            },
            {
                "first": "Giovannalberto",
                "middle": [],
                "last": "Pini",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Evangelos",
                "middle": [],
                "last": "Liatsikos",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Patras",
                    "location": {
                        "settlement": "Patras",
                        "country": "Greece"
                    }
                },
                "email": ""
            },
            {
                "first": "Gianluca",
                "middle": [],
                "last": "Giannarini",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Academic Medical Centre Hospital \"",
                    "location": {
                        "addrLine": "Santa Maria della 27 Misericordia\"",
                        "settlement": "Udine",
                        "country": "Italy"
                    }
                },
                "email": ""
            },
            {
                "first": "Alex",
                "middle": [],
                "last": "Mottrie",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Onze Lieve Vrouw Hospital",
                    "location": {
                        "settlement": "Aalst",
                        "country": "Belgium"
                    }
                },
                "email": ""
            },
            {
                "first": "Ramnath",
                "middle": [],
                "last": "Subramaniam",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Leeds Teaching Hospitals NHS Trust",
                    "location": {
                        "settlement": "Leeds",
                        "country": "UK"
                    }
                },
                "email": ""
            },
            {
                "first": "Nikolaos",
                "middle": [],
                "last": "Sofikitis",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University Campus",
                    "location": {
                        "settlement": "Ioannina, 29",
                        "country": "Greece"
                    }
                },
                "email": ""
            },
            {
                "first": "Bernardo",
                "middle": [
                    "M C"
                ],
                "last": "Rocco",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Modena and Reggio Emilia",
                    "location": {
                        "settlement": "Modena",
                        "country": "Italy"
                    }
                },
                "email": ""
            },
            {
                "first": "Li-Ping",
                "middle": [],
                "last": "Xie",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Zhejiang University",
                    "location": {
                        "addrLine": "Zhejiang Province",
                        "settlement": "Hangzhou",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "J",
                "middle": [
                    "Alfred"
                ],
                "last": "Witjes",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Radboud University Medical Center",
                    "location": {
                        "settlement": "Nijmegen, 31",
                        "country": "The Netherlands"
                    }
                },
                "email": ""
            },
            {
                "first": "Nicolas",
                "middle": [],
                "last": "Mottet",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University Hospital",
                    "location": {
                        "addrLine": "St. Etienne",
                        "country": "France"
                    }
                },
                "email": ""
            },
            {
                "first": "B\u00f6rje",
                "middle": [],
                "last": "Ljungberg",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Ume\u00e5 University",
                    "location": {
                        "settlement": "Ume\u00e5",
                        "country": "Sweden"
                    }
                },
                "email": ""
            },
            {
                "first": "Morgan",
                "middle": [],
                "last": "Roupr\u00eat",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Sorbonne University",
                    "location": {
                        "addrLine": "GRC 5 Predictive onco-uro, AP-HP, Pitie-Salpetriere Hospital",
                        "settlement": "Urology, Paris",
                        "country": "France"
                    }
                },
                "email": ""
            },
            {
                "first": "Maria",
                "middle": [
                    "P"
                ],
                "last": "Laguna",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Istanbul Medipol University",
                    "location": {
                        "settlement": "Istanbul",
                        "country": "Turkey"
                    }
                },
                "email": ""
            },
            {
                "first": "Andrea",
                "middle": [],
                "last": "Salonia",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "IRCCS Ospedale San Raffaele",
                    "location": {
                        "settlement": "Milan",
                        "country": "Italy"
                    }
                },
                "email": ""
            },
            {
                "first": "Gernot",
                "middle": [],
                "last": "Bonkat",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Bertil",
                "middle": [
                    "F M"
                ],
                "last": "Blok",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Christian",
                "middle": [],
                "last": "T\u00fcrk",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Christian",
                "middle": [],
                "last": "Radmayr Ff",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Noam",
                "middle": [
                    "D"
                ],
                "last": "Kitrey",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Daniel",
                "middle": [
                    "S"
                ],
                "last": "Engeler",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Nicolaas",
                "middle": [],
                "last": "Lumen",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Oliver",
                "middle": [
                    "W"
                ],
                "last": "Hakenberg Jj",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Nick",
                "middle": [],
                "last": "Watkin",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Julie",
                "middle": [],
                "last": "Darraugh",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Robert",
                "middle": [],
                "last": "Shepherd",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Emma-Jane",
                "middle": [],
                "last": "Smith",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Christopher",
                "middle": [
                    "R"
                ],
                "last": "Chapple",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Arnulf",
                "middle": [],
                "last": "Stenzl",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Hendrik",
                "middle": [],
                "last": "Van Poppel",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Manfred",
                "middle": [],
                "last": "Wirth",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Jens",
                "middle": [],
                "last": "S\u00f8nksen",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "James",
                "middle": [],
                "last": "N&apos;dow",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "James",
                "middle": [],
                "last": "Catto",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [
        {
            "text": "on behalf of the EAU Section Offices and the 17 EAU Guidelines Panels 18 E U R O P E A N U R O L O G Y X X X ( 2 0 1 9 ) X X X -X X X a v a i l a b l e a t w w w . s c i e n c e d i r e c t . c o m j o u r n a l h o m e p a g e : w w w . e u r o p e a n u r o l o g y . c o m $ Please see the Supplementary material for all members of the Guidelines Office Rapid Response Group (GORRG), the EAU Guidelines Panels, and the EAU Section Offices. 44 93 were discussed and approved by panel members across 94 21 EAU Guideline Panels using electronic communication.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "Regarding surgical approach that applies across several 96 guidelines, it was decided that the GORRG will provide 97 general recommendations instead of guideline-specific 98 surgical approach recommendations in each disease area.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "All panels were provided the following specific terms of 100 reference.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "The coronavirus disease 2019 (COVID-19) pandemic is unlike anything seen before by modern science-based medicine. Health systems across the world are struggling to manage it. Added to this struggle are the effects of social confinement and isolation. This brings into question whether the latest guidelines are relevant in this crisis. We aim to support urologists in this difficult situation by providing tools that can facilitate decision making, and to minimise the impact and risks for both patients and health professionals delivering urological care, whenever possible. We hope that the revised recommendations will assist urologist surgeons across the globe to guide the management of urological conditions during the current COVID-19 pandemic.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        }
    ],
    "body_text": [
        {
            "text": "The coronavirus disease ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Introduction"
        },
        {
            "text": "In addition, there are some overarching principles that 221 should be emphasised (as presented in Table 2 ). In order to [16] .6.CO 2 insufflation should be utilised with a closed system with appropriate filtering of aerosolised particles:(a)It should be ensured that 8 mm instruments are not inserted in a 12 mm da Vinci trocar without a reducer.(b)It should be ensured that a 5 mm instrument is not inserted in a 12 mm da Vinci trocar even with the reducer in place.(c)CO 2 insufflation should be turned off and the gas should be vented through a filter prior to specimen extraction.(d) Consultation with the CO 2 insufflation manufacturer used in your hospital may be necessary to ensure that proper settings are selected for maximal filtration effect.(e)The full recommendation of SAGES on this topic as well as the cited published evidence can be found on the SAGES website [16] . A recent publication that reports the experience of minimally invasive surgeons from China and Italy in the setting of known/suspected COVID-19 can be accessed from the Annals of Surgery [8] .7.For (robot-assisted) laparoscopy and retroperitoneoscopy, the lowest allowed intra-abdominal pressure with the use of intelligent integrated Insufflation systems is recommended (ERUS) [7] .8.It is recommended that electrocautery power setting be lowered as much as possible in order to reduce the surgical smoke production, especially in laparoscopic surgery. During access, electrocautery should be provided with automatic suction system.9.Evacuation of irrigation fluid during endourological procedures (cystoscopy, TURB, BPH, endoscopic surgery, URS, RIRS, and PCNL) should be collected through a close system. General guidance for testing patients before surgery in the COVID-19 period 1.Patients with clinical symptoms such as fever and respiratory distress and/or with a travel history to endemic areas and previous contact with COVID-19 patients should all undergo preoperative COVID-19 test. In an emergency situation, it is suggested that these patients should be handled as COVID-19-positive patients in order to reduce the risk of contagion for both patients and health care workers.2.Among patients without any clinic symptoms, without a travel history to endemic areas, and without previous contact in the past 2 wk with a COVID-19-positive patient, testing of elective patients is recommended whenever possible within 48 h prior to surgery in an outpatient clinic setting. One may consider starting with PCR testing and withholding a chest CT only if the PCR is positive for a COVID-19 infection. However, this might have severe logistical implications (patients need to visit the hospital repeatedly), and joint testing of PCR and CT may be a more desirable and practical approach, depending on the local situation. The main reasons for that approach are as follows:(a)Patients may be in the incubation period of a COVID-19 infection and subsequently develop COVID-19 postoperatively, placing them at risk for adverse postoperative outcomes [6] . (b)Patients may be asymptomatic/mildly symptomatic carriers and shedders of SARS-CoV-2 and place hospital workers at risk, particularly during intubation and aerosolising procedures.(c)Patients may be asymptomatic/mildly symptomatic carriers and shedders of SARS-CoV-2 and place other hospitalised patients at risk, who are often in higher age groups with comorbidities and at higher risk of severe COVID-19 disease.3.The group is aware that, at present, different triage policies may be applicable depending on the region or country. Even following accounts of the false negative results of the test and the fact that PPE has to be adopted in all surgical patients, information on the test may be useful in the postoperative period.4.In addition, we strongly recommend advising patients to comply with general directions regarding social distancing as stated by the government, since this will likely lower the risk for COVID-19 disease at the time of operation. General guidance on other assistance aspects beyond surgery 1.Telemedicine.2.Potential or proven COVID-19-positive patients must be treated according to local, national, and WHO requirements [18] . In this case, a comprehensive and robust infection control workflow has to be followed [20].3.A network of expert high-volume centres, at the regional, national, or even supranational level, should guarantee the continuity of the oncological care in an appropriate way, ensuring the availability of hospital beds and timely management of new patients.4.Remote consultation and a multidisciplinary team are recommended to offer the optimum therapeutics.5.Testing for SARS-CoV-2 should be considered before any high-dose chemotherapy.6.Patients should be guided to get access to nonemergency medical services such as chronic disease treatment online to reduce the number of visitors in hospitals.7.Patients should be encouraged to take full advantage of digital self-service devices to avoid contact with others, to reduce the risk of cross infections. s12630-020-01617-4.",
            "cite_spans": [
                {
                    "start": 121,
                    "end": 125,
                    "text": "[16]",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 879,
                    "end": 883,
                    "text": "[16]",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 1073,
                    "end": 1076,
                    "text": "[8]",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 1264,
                    "end": 1267,
                    "text": "[7]",
                    "ref_id": null
                },
                {
                    "start": 3036,
                    "end": 3039,
                    "text": "[6]",
                    "ref_id": null
                },
                {
                    "start": 4197,
                    "end": 4201,
                    "text": "[18]",
                    "ref_id": null
                }
            ],
            "ref_spans": [
                {
                    "start": 98,
                    "end": 105,
                    "text": "Table 2",
                    "ref_id": "TABREF3"
                }
            ],
            "section": "220"
        },
        {
            "text": "E U R O P E A N U R O L O G Y X X X ( 2 0 1 9 ) X X X -X X X ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "220"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Worldometer COVID-19 data",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "European Association of Urology Guidelines Office",
            "authors": [],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Urology practice Q9",
            "authors": [
                {
                    "first": "V",
                    "middle": [],
                    "last": "Ficarra",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Novara",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Abrate",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Covid-19: four fifths of cases are asymptomatic, China 477 figures indicate",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Day",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "BMJ",
            "volume": "369",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "COVID-19 infection. EClinicalMedicine",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1016/j.eclinm.2020.100331"
                ]
            }
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Urology Section) guidelines during COVID-19 482 emergency",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Erus (eau Robotic",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "EAU Robotic Urology Section. ERUS",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "Minimally invasive surgery and the 484 novel coronavirus outbreak: lessons learned in China and Italy",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "H"
                    ],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Boni",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Fingerhut",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Ann",
            "volume": "485",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "press",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Surg",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1097/SLA.0000000000003924"
                ]
            }
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "WHO. Laboratory testing for coronavirus disease 2019",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "Persistence and clearance of viral RNA in 492",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Ling",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "B"
                    ],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "X"
                    ],
                    "last": "Lin",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "Enteric involvement of coronaviruses: is 498 faecal-oral transmission of SARS-CoV-2 possible?",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Yeo",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kaushal",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Yeo",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet Gastroenterol Hepatol",
            "volume": "5",
            "issn": "",
            "pages": "335--342",
            "other_ids": {}
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "Global telemedicine imple-500",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Ohannessian",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "A"
                    ],
                    "last": "Duong",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Odone",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "Virtually perfect? Telemedicine for Covid-19",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "E"
                    ],
                    "last": "Hollander",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "G"
                    ],
                    "last": "Carr",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "press",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1056/NEJMp2003539"
                ]
            }
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "J"
                    ],
                    "last": "Ribal",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Eur Urol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1016/j.eururo.2020.04.056"
                ]
            }
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "COVID-19) pandemic is unlike 45 anything seen before by modern science-based medicine. As 46 of April 14, 2020, there are 1933 800 confirmed cases globally 47 in 210 countries and 120 434 deaths [1]. Health systems 48 globally have struggled. Anaesthetists and theatre teams 49 have been redeployed, and intensive care units (ICUs) 50 struggle with demands as the entire service is refocused 51 on managing the acutely unwell. Added to this are the effects 52 of social confinement and isolation. Staff at risk are removed 53 from the workforce for their own health and some of them get 54 sick, also limiting capacity. This brings into question whether 55 the latest guidelines based upon the best evidence and 56 published only 2 wk ago are relevant in this crisis. 57 As a scientific society and via the guidelines, section 58 offices, and the European Urology family of journals, we 59 believe that it is important that we try to support urologists 60 in this difficult situation. We aim to do this by providing 61 tools that can facilitate decision making. Our goal is to 62 minimise the impact and risks for both patients and health 63 professionals delivering urological care, whenever possible, 64 although it is clear that it is not always possible to mitigate 65 them entirely. It should be understood that there may not be 66 high-quality evidence for the compromises proposed, but 67 we hope that this document will function as an important 68 additional guide to the management of urological condi-69 tions during the current COVID-19 pandemic, caused by 70 severe acute respiratory syndrome coronavirus 2 (SARS-71 CoV-2), based on the current European Association of 72 Urology (EAU) guidelines. GORRG) on March 19, 2020 to facilitate the 75 development of adapted guidelines, to deal with a range 76 of situations and priorities. Using the resources of the 77 Guidelines Office, the panel chairmen, and panel members, 78 in collaboration with other relevant EAU section offices 79 plus the Executive Committee, the aim was to ensure an 80 aligned organisation-wide consensus and response under-81 pinned by the best knowledge at our disposal describing 82 how to react to the urgent crisis impacting urological care 83 and services. All recommendations in the guidelines have been 84 reviewed in light of the COVID-19 pandemic and have 85 been adapted where appropriate. Panels also had access 86 to and reviewed a range of national and local COVID-19 87 guidelines to ensure complementarity wherever possible.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": "status and age of the patient, especially given the 172 risks of concurrent COVID-19 infection during recovery 173 Urgency of the procedure 174 Risk of bleeding/transfusion-there is a lack of red blood 175 cell units because blood donors do not go to the hospital. Co-176 morbidities such as chronic obstructive pulmonary disease 177 should be taken into account; patients taking anticoaguall 17 EAU Guideline Panels, the GORRG",
            "latex": null,
            "type": "figure"
        },
        "FIGREF2": {
            "text": ", a second-step peer-reviewing process was done 194 by seven independent Section Office members (three 195 experts in oncology and three in nononcology, and one to 196 comment on both oncology and nononcology); we also 197 sought peer-review comments from China, given the 198 significant experience they have had with COVID-19 and 199 being a few months ahead of Europe in terms of stage of 200 pandemic and recovery. 201 After the second round of peer-review process, different 202 recommendations have been released and these can be 203 consulted in 17 guideline topics provided in Supplementary 204 Tables 1-17.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF3": {
            "text": "guidance produced is based on expert opinion and 207 consensus building across the EAU with contributions from 208 all 250 members of the EAU Guidelines Office and with 209 contributions from the 130 key opinion leaders forming the 210 membership of the EAU Section Offices. It is important to 211 emphasise that during the rapidly evolving COVID-19 212 pandemic, this guidance may further change and critically 213 will require adaptation to local resources, health systems, 214 and specific circumstances of each country or city, bearing 215 in mind that different countries and indeed different cities 216 are likely to be at different phases of the pandemic and 217 national/local health system capacities must dictate the 218 level of prioritisation implemented in line with local COVID-",
            "latex": null,
            "type": "figure"
        },
        "FIGREF4": {
            "text": "minimise the number of staff who become infected, all 223 medical personnel should comply with the PPE regulations.224 If possible, patients should be asked whether they are at risk 225 of COVID-19 prior to any visit in a practice or clinic or 226 hospital setting. Patients who are currently known to be 227 shedding COVID-19 virus should postpone any investiga-228 tions of other symptoms unless they are thought to be life 229 threatening. However, urologists working in hospitals 230 treating COVID-19 patients may be required to perform 231 urgent investigations on infected patients. In these cases, 232 procedures should be performed in dedicated consultation 233 or operating rooms following the hospital recommendation 234 for staff PPE. Even following a negative COVID-19 test result, 235 it is important to remember the relatively high risk of a false 236 negative result and, as a consequence, ensure that all the 237 necessary PPE tools and general recommendations to 238 reduce COVID-19 transmission are adequately followed 239 (",
            "latex": null,
            "type": "figure"
        },
        "FIGREF5": {
            "text": "Levels of priority. A&E = Accident & Emergency Department.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF6": {
            "text": "BPH = benign prostatic hyperplasia; COVID-19 = coronavirus disease 2019; CT = computed tomography; EAU = European Association of Urology; ERUS = EAU Robotic Urology Section; ICU = intensive care unit; OR = operating room; PCNL = percutaneous nephrolithotomy; PCR = polymerase chain reaction; RIRS = retrograde intrarenal surgery; SARS-COV-2 = severe acute respiratory syndrome coronavirus 2; TURB = transurethral resection of the bladder; URS = ureterorenoscopy. a Disclaimer: The EAU Guidelines Office COVID-19 recommendations are to support health care systems under severe constrain during the pandemic, but their application should be modulated according to local pandemic conditions and restrictions in clinical and surgical activity due to local medical directives and guidance.",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "evidence to adapted recommendation. In order to achieve this, the GORRG produced a colour-coded risk stratification 125 tool(Table 1)for completion by guideline panels to aid them 126 with the adaption of their recommendations:High priority: the last to cancel, prevent delay of >6 wk;",
            "latex": null,
            "type": "table"
        },
        "TABREF1": {
            "text": "Levels of priority Q1.",
            "latex": null,
            "type": "table"
        },
        "TABREF3": {
            "text": "[3]. It is also prudent during this pandemic, in the isolation/quarantine strategies in place, that health professionals perform their duties on the presumption that all patients they treat are potentially infected with COVID-19 even if asymptomatic, given that there is increasing 245 evidence of high infection rates in asymptomatic individuals in countries conducting extensive community testing of 247 their citizens[4,5]. In this regard, it is important to consider 248 the risk not only for staff but also for the patients. Recent evidence from Wuhan reported a 20% mortality rate in asymptomatic patients who tested COVID positive after the procedures, which are equivalent to urological transabdominal or retroperitoneal interventions, seven died in ICU from acute respiratory distress syndrome(Table 2).If surgical procedures are unavoidable, it is recommended that all procedures should be performed by experienced urologists confident in the procedure. They should be performed with the minimum number of staff members, who should also be fully trained and experienced.Furthermore, no external observers should be present",
            "latex": null,
            "type": "table"
        },
        "TABREF5": {
            "text": "General recommendations applicable during the COVID-19 pandemic. a General recommendations for surgical procedures 1.Depending on the resources and capacity, we recommend treating only high-priority and emergency cases surgically during the COVID pandemic.2.Consider not only equipment, OR, and ICU bed capacity, but also blood supplies available and drug shortage, in order to prioritise your surgeries.3.Consider that even if capacity is available, low-priority patients increase the footfall and the risk of COVID transmission between patients and staff.4.Consider that surgery has been reported to be harmful in asymptomatic patients who subsequently tested COVID positive[6].5.Consider treating intermediate-priority patients if capacity is available but not during the COVID surge.6.Consider older patients with comorbidity at severe risk of COVID infection and a fatal outcome. Therefore, carefully balance if surgery is the only alternative in high-priority cases.7.Where ventilator capacity for COVID patients has been breached, high-priority surgical candidates requiring ICU ventilation should be triaged according to local recommendations-or if unavailable-age and comorbidity.8.Follow the local recommendations to test staff and patients for COVID, if resources are available. These may differ across hospitals and countries; you should familiarise yourself with them. Be aware that they may change as new information is coming in.9.Follow the local recommendations for personal protective equipment (PPE), if resources are available; the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) advise full PPE irrespective of COVID status of the patient. Familiarise yourself with their recommendation[16,17].10.Wear full PPE for COVID-positive patients according to the World Health Organization (WHO). This should include double gloves, gowns, face shields, and virus-proof masks [17,18].11.Intubation and extubation should preferably take place in a negative pressure room if available[19].12.All nonessential staff should stay outside the operating room during the procedure.13.Set electrosurgery units to the lowest possible settings to reach the required effect.14.Avoid or reduce the use of monopolar electrosurgery, ultrasonic dissectors, and advanced bipolar devices, as these can lead to particle aerosolisation.15. Use, if available, monopolar diathermy handheld devices with attached smoke evacuators.16.Clean surgical equipment of COVID-positive or suspected patients separately.General guidance on what to do when faced with a known COVID-19-positive patient needing surgery (these measures are partially also applicable to COVID-19-negative patients) 1.A specially equipped dedicated OR has to be prepared for these cases. For endourology, a mobile C-arm fluoroscopic x-ray system for radiological imaging and an experienced personnel for its handling has to be in the special OR.2.Surgeons and operating team (surgeons, anaesthetists, nurses, technicians, nursing assistants/ health care workers, and hospital housekeepers) in the OR should be completely protected against infection of COVID-19 and adopt adequate protection devices.3. All minimally invasive procedures should preferably be performed by experienced surgeons, and the number of experienced OR staff members required should be minimum. Additionally, no external observer is allowed in the OR[7] (https://uroweb.org/wp-content/uploads/ERUS-guidelines-for-COVID-def.pdf).4.To date, there are no specific data demonstrating an aerosol presence of the COVID-19 virus released during minimally invasive abdominal surgery.5.Smoke evacuation systems with active filtered smoke evacuation mode, capable of filtering the aerosolised particles from the carbon dioxide, should be provided during laparoscopic surgeries",
            "latex": null,
            "type": "table"
        },
        "TABREF6": {
            "text": "should be taken following local protocols.It is now clear that SARS-CoV-2 is present in the stools of COVID-19 patients. Therefore, the transmission during various procedures (eg, transrectal prostate biopsy and urinary diversions) might be possible[13]. Therefore, even if clear evidence of COVID-19 virus spreading through faeces is not demonstrated yet, it is preferable to minimise the risks of faecal transmissions. Social distancing is the key player to fight against COVID-19 pandemic. We have a duty to avoid unnecessary outpatient visits and in doing so reduce the chance of virus transmission. Increasing use of telehealth may be an important way to continue to support patients and their carers during this crisis. It will be interesting to see if this change, born of necessity, is incorporated into urological practice beyond the pandemic (Table 2) [14,15].While it cannot be predicted when we will be able to revert back from the acute phase of the COVID-19 pandemic and resume more normal levels of urological care, we need to plan ahead on how the urological community should do this.The most logical step will be to reverse back through the aforementioned prioritisation stages. During this process, we will need to confer with our fellow surgical (sub) specialities to prioritise the available surgical time and resources among all surgical patients.Undoubtedly there will be cases where the optimal surgical treatment time point will be surpassed. These patients may be at risk of a suboptimal outcome or an increased psychological burden due to delayed surgery, and should be prioritised in the long waiting lists that we will undoubtedly be facing on the other end of this crisis.The EAU is a family of 19 000 members, and beyond our membership, the EAU feels a huge sense of responsibility towards each and every urologist globally, wherever they may be, appreciating that the EAU guidelines are now endorsed by national societies of 72 countries. This extended family ethos is even more important at a time like this when we are acutely aware of the despair that nations and their citizens are experiencing around the world. For instance, we realise that our colleagues and friends in Italy, Spain, France, UK, other EU member states and increasingly in the USA are being particularly impacted, whilst on the other side of the world, our friends in China, South Korea, and Japan look to rebuild and return to some form of new normality. Our thoughts are with each and every one of you. Despite these incredibly difficult times, key opinion leaders across the breadth of our membership have come together like never before to rapidly produce this publication on adapting EAU guideline recommendations to COVID-19 that we hope will fill an important urological practice void and assist urologist surgeons across the globe as they do their very best to deal with the crisis of our generation. The EAU Guidelines Office COVID-19 recommendations can be consulted in Supplementary Tables 1-17. Author contributions: Maria J. Ribal had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Ribal, N'Dow, Cornford, Briganti, Knoll, Gravas, is a company consultant for Astellas, Janssen, Opko Health, MDx Health, and Bayer; received company speaker honorarium from Astellas and Ferring; and received research support from Sandoz. Thomas Knoll is a company consultant for Storz Medical, Dornier, Olympus, and Boston Scientific; received company speaker honorarium from Boston scientific; received fellowship/travel grants from Cook; and received research support from Dornier. Stavros Gravas is a company consultant for 2020;3:1. [18] WHO. Rational use of personal protective equipment (PPE) for coronavirus disease (COVID-19): interim guidance, 19 March 2020. World Health Organization https://apps.who.int/iris/ 514 [19] Organisations IC. Information, guidance and resources supporting the understanding and management of coronavirus (COVID-19)ICM Anaesthesia COVID-19. 2020 In: https://icmanaesthesiacovid-19. Ti LK, Ang LS, Foong TW, Ng BSW. What we do when a COVID-19 patient needs an operation: operating room preparation and guidance. Can J Anaesth. In press. https://doi.org/10.1007/",
            "latex": null,
            "type": "table"
        },
        "TABREF7": {
            "text": "Please cite this article in press as:Ribal  MJ, et al. European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era. Eur Urol (2020), https://doi.org/10.1016/j.eururo.2020.04.056",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}